Overview

Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme

Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and performance of an investigational agent, known as 5-ALA or Gliolan (aminolevulinic acid), that many be useful to a surgeon for visualizing a tumor during surgery. It is also being studied to determine if there are differences in what Gliolan shows a surgeon compared to intraoperative magnetic resonance imaging (MRI)
Phase:
Phase 2
Details
Lead Sponsor:
Michael Vogelbaum, MD, PhD
Collaborator:
National Cancer Institute (NCI)
Treatments:
Aminolevulinic Acid